Resources

Biovance 3L Ocular – Overview Sheet

Biovance 3L Ocular Product Brochure

Biovance 3L Ocular – Clinical Application Process

Biovance 3L Ocular – Clinical Application Process [VIDEO]

Biovance 3L Ocular – Pterygium Surgery Application Process

Biovance 3L Ocular – Glueless, Sutureless Pterygium Surgery [VIDEO]

Biovance 3L Ocular – Order Form

Biovance 3L Ocular – Insurance Verification Form

2024 Medicare Ocular Reimbursement Codes Flashcard

Biovance 3L Ocular – Benchtop Study Reprint

Biovance 3L Ocular – Case Study – Anterior Membrane Dystrophy

Peer-Reviewed Article entitled “An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study”; Mao Y. et al; J Biomed Mater Res. 2022;1–17.

Peer-Reviewed Article entitled “Surgical Time and Postoperative Symptoms Study in Pterygium Excision and Amniotic Membrane Graft Using Celularity Triple Layer Dehydrated Amniotic Membrane“; Rivera-Morales P. et al; Clin Ophthal 2023:17;1967-1974. https://doi.org/10.2147/OPTH.S410452

Ophthalmology Times Article – Novel Amniotic Membrane: A Step Ahead of Other Scaffolds for Pterygia

Ophthalmology Times Article – 3-layer amniotic membrane successfully treats severe case of keratoconjunctivitis sicca

Healio Article – Biovance 3L Ocular effective in patients with chronic ocular surface disease

eyetube Video: Glueless, Sutureless Pterygium Surgery With Amniotic Membrane

Verséa is a registered trademark of Verséa Health, Inc.

©2024 Verséa Ophthalmics, Inc. All rights reserved.

https://www.versea.com/wp-content/uploads/2024/03/Versea-Ophthamics_wordmark_icon_white.png

If you would like to learn more about our Tear-based Point-of-Care (T-POC) Quantitative Testing Platform or Biovance 3L Ocular, please contact us at ophthalmics@versea.com